775349-40-1 Usage
Description
4-METHYL-1-PIPERAZINEPROPANOIC ACID HYDROCHLORIDE is a chemical compound characterized by a piperazine ring with a propionic acid and a methyl group attached to it. It is typically found in the form of a white to off-white crystalline powder and is insoluble in water.
Used in Pharmaceutical Industry:
4-METHYL-1-PIPERAZINEPROPANOIC ACID HYDROCHLORIDE is used as an intermediate in the synthesis of pharmaceuticals and organic compounds, playing a crucial role in the development of new drugs for various medical applications.
Used in Dye and Pigment Manufacturing:
4-METHYL-1-PIPERAZINEPROPANOIC ACID HYDROCHLORIDE is used as a component in the manufacturing of dyes and pigments, contributing to the production of a wide range of colorants for different industries.
Used in Research and Scientific Studies:
4-METHYL-1-PIPERAZINEPROPANOIC ACID HYDROCHLORIDE is used as a reagent or building block for chemical synthesis in research and scientific studies, facilitating the exploration of new chemical compounds and their potential applications.
Check Digit Verification of cas no
The CAS Registry Mumber 775349-40-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,7,5,3,4 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 775349-40:
(8*7)+(7*7)+(6*5)+(5*3)+(4*4)+(3*9)+(2*4)+(1*0)=201
201 % 10 = 1
So 775349-40-1 is a valid CAS Registry Number.
775349-40-1Relevant articles and documents
MODIFIED DRUGS FOR USE IN LIPOSOMAL NANOPARTICLES
-
, (2018/08/25)
Drag derivatives are provided herein which are suitable for loading into liposomal nanoparticle carriers. In some preferred aspects, the derivatives comprise a poorly water-soluble drag derivatized with a weak-base moiety that facilitates active loading of the drag through a LN transmembrane pH or ion gradient into the aqueous interior of the LN. The weak-base moiety can optionally comprise a lipophilic domain that facilitates active loading of the drag to the inner monolayer of the liposomal membrane. Advantageously, LN formulations of the drag derivatives exhibit improved solubility, reduced toxicity, enhanced efficacy, and/or other benefits relative to the corresponding free drags.
